Effects of Magnetic Tape on the Autonomic Nervous System

Sponsor
Florida Gulf Coast University (Other)
Overall Status
Completed
CT.gov ID
NCT05504369
Collaborator
University of Valencia (Other)
25
1
2
18
1.4

Study Details

Study Description

Brief Summary

The effect of magnetic tape on pain and autonomic nervous system in subject with lower back pain.

Condition or Disease Intervention/Treatment Phase
  • Other: Magnetic tape
  • Other: Placebo tape
N/A

Detailed Description

The effects of magnetic nanoparticles in tape applied in the lumbar spine on the autonomic nervous system measured with fully automated pupillometry and on pain in the spine measured with posterior to anterior pressure on the spinous process and the skin pinch test paravertebrally

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single group design with random allocation of intervention placebo versus treatment tape. Next day other intervention was usedSingle group design with random allocation of intervention placebo versus treatment tape. Next day other intervention was used
Masking:
Double (Participant, Investigator)
Masking Description:
Participant and researchers where not aware of the magnetic tape versus placebo tape as the look and feel identical
Primary Purpose:
Basic Science
Official Title:
Effects of Magnetic Tape on the Autonomic Nervous System
Actual Study Start Date :
Jan 1, 2020
Actual Primary Completion Date :
Jul 1, 2021
Actual Study Completion Date :
Jul 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Magnetic tape arm

Tape application bilaterally in the lumbar spine

Other: Magnetic tape
Tape with magnetic nanoparticles applied to the skin

Sham Comparator: Placebo tape arm

Tape application bilaterally in the lumbar spine

Other: Placebo tape
Tape without nano particles applied to the skin

Outcome Measures

Primary Outcome Measures

  1. Pupillometry [60 seconds measure preceding tape application. After outcome 5]

    1 minute continues pupil diameter measure

  2. Pupillometry [Second 60 second measure immediate after tape application. After outcome 1]

    1 minute continues pupil diameter measure

  3. Pupillometry [Third 60 measure 3 minutes after the tape is removed. After outcome 2]

    1 minute continues pupil diameter measure

Secondary Outcome Measures

  1. PA spine [First PA measure of 5 seconds on each PA of 5 seconds on each segment is starting off the measurement phase. This is the first outcome measure]

    Anterior (PA) pressure on each spinal segment

  2. Skin pinch test [3 seconds skin pinch test at each level starting immediately following the first PA measure. After Outcome 4]

    Bilaterally of each vertebrae

  3. PA spine [Five second measure of PA of 5 seconds each segment is taken immediately after the third pupillometry measure (tape removed). After outcome 3]

    Anterior (PA) pressure on each spinal segment

  4. Skin Pinch test [3 seconds skin pinch test at each level starting immediately following outcome 6]

    Bilaterally of each vertebrae

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Current lower back pain with NPRS of 5

  • Between ages 18-65

Exclusion Criteria:
  • No lower back pain or pain <5 on the NPRS

  • Not meeting age limit

  • Having condition that prevents the PA procedure

  • Conditions of the nervous system and inability keep eyes open

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Valencia Valencia De Alcántara Spain 46010

Sponsors and Collaborators

  • Florida Gulf Coast University
  • University of Valencia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Rob Sillevis,, Associate Professor, Florida Gulf Coast University
ClinicalTrials.gov Identifier:
NCT05504369
Other Study ID Numbers:
  • 1240878
First Posted:
Aug 17, 2022
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Rob Sillevis,, Associate Professor, Florida Gulf Coast University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2022